ClinicalTrials.Veeva

Menu

Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies

M

Ministry of Science and Technology of the People´s Republic of China

Status and phase

Unknown
Phase 4

Conditions

Twin Pregnancy
Preeclampsia
Fetal Growth Restriction
Preterm Birth

Treatments

Drug: Aspirin 100mg

Study type

Interventional

Funder types

Other

Identifiers

NCT04051567
M2017047

Details and patient eligibility

About

Twin pregnancies are associated with increased risk of perinatal adverse outcomes , including preeclampsia , fetal growth restriction , preterm premature rupture of membranes and preterm birth. Low-dose aspirin was recommend by American College of Obstetricians and Gynecologists (ACOG) during pregnancy. In this trial, the investigators suppose that aspirin used in twin-pregnancies could improve adverse pregnancy outcomes.

Enrollment

425 estimated patients

Sex

Female

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Twin pregnancy diagnosed by ultrasound and maternal age ranged from 18 to 55 years, Gestational age was less than 16w

Exclusion criteria

  • Diagnosed fetal anomalies, history of cervical cerclage, contraindications of aspirin, pre-existing renal or liver diseases or abnormal functions, coagulation disorders, history of PE, preterm birth or FGR, chronic hypertension

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

425 participants in 2 patient groups

LDA group
Experimental group
Treatment:
Drug: Aspirin 100mg
NC group
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems